My primary objective in the U.S. is to leverage advanced research infrastructure and foster international partnerships to address pressing biochemical and public health issues. I aim to:

1. Expand Research on Metabolic Disorders: Building on my work with adipokines (e.g., adiponectin, leptin), I plan to investigate their role in chronic conditions like diabetes and cardiovascular diseases within diverse populations. The U.S. offers cutting-edge tools for metabolomics and genetic analysis, enabling deeper insights into biomarkers for early disease detection and personalized therapies. Collaborating with institutions like the NIH or universities with strong endocrinology departments will amplify this work.
2. Integrate AI into Medical Education: My recent studies on ChatGPT’s impact on academic integrity and hybrid learning models (published in Frontiers in Educationand BMC Medical Education) highlight the transformative potential of AI. In the U.S., I intend to design AI-driven curricula that enhance clinical reasoning and adaptive learning. Partnering with centers like Stanford’s AIMI or Johns Hopkins’ Institute for Educational Excellence will allow me to develop scalable frameworks for global medical education reform.
3. Investigate Environmental Health Risks: A project in process of funding on microplastics in blood samples (submitted to NIH) aligns with growing U.S. interest in environmental toxins. I have found microplastics in 10 human samples in a pilot study in Pakistani Individuals as a pioneer investigation. This study is in pipeline for publication. I aim to analyze microplastic exposure’s correlation with inflammatory biomarkers and metabolic dysregulation, utilizing advanced spectrometry and biorepositories. This work could inform policy interventions to mitigate health disparities in vulnerable communities.
4. Telomere Biology and Chronic Disease: My proposed study on telomere attrition in hypertensive populations (submitted to RAC KSA) seeks to explore genetic and lifestyle factors driving cellular aging. Access to U.S. genomic databases and longitudinal cohorts will facilitate large-scale analyses, bridging gaps in preventive cardiology research.

“I plan to continue working in my field as Faculty position at Nova SouthEastern University Lakeland in Polk County, Florida , where I have applied recently for Foundation course in pathophysiology. Being Medical educationist and Professor of Biochemistry I am confident to make the course interesting through PBL and TBL learning strategies.

I have also applied for position of Biochemistry and Molecular Biology Associate Professor at University of Miami, Florida to continue my profession in Biochemistry and Molecular Biology. I will pursue collaborative grants (e.g., NSF, NIH R01), engage with interdisciplinary consortia, and contribute to translational research initiatives. My experience in curriculum design and workshop facilitation positions me to lead training programs on AI literacy and evidence-based pedagogy. Additionally, I aim to establish a cross-cultural research network linking U.S. and South Asian institutions to address shared health challenges, such as diabetes and environmental toxicity.

I have also applied for Faculty position of Medical Biochemistry at International University School of Medicine (IUSOM) Caribbean Islands to continue my career as Medical Biochemist in Teaching and Research.

By merging my expertise in biochemistry, medical education, and leadership, I am eager to contribute to innovative solutions that advance global health equity and scientific discovery in the U.S. academic landscape.